Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Find out How Index Funds are Traded, Priced & Potential Issues You May Face

Mutualfunds logo

GGHCX Invesco Global Health Care A

  • Fund
  • GGHCX
  • Price as of: Jul 24, 2017
  • $38.82
  • + $0.05
  • + 0.13%
  • Category
  • Health & Biotech Equities

GGHCX - Profile

Vitals

  • YTD Return 17.9%
  • 3 Yr Annualized Return 4.5%
  • 5 Yr Annualized Return 13.8%
  • Net Assets $1.45 B
  • Holdings in Top 10 37.4%

52 WEEK LOW AND HIGH

$38.82
$31.90
$38.82

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.09%

SALES FEES

  • Front Load 5.50%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 21.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$250

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 17.9%
  • 3 Yr Annualized Total Return 2.5%
  • 5 Yr Annualized Total Return 12.5%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.23%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Invesco Global Health Care Fund
  • Fund Family Name Invesco
  • Inception Date Aug 07, 1989
  • Shares Outstanding N/A
  • Share Class A
  • Currency USD
  • Domiciled Country United States
  • Manager Derek Taner

GGHCX - Performance

Return Ranking - Trailing

Period GGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 17.9% -14.9% 33.8% 69.64% 4
1 Yr 11.8% -14.8% 43.3% 71.17% 4
3 Yr 4.5% * -7.5% 18.2% 87.96% 5
5 Yr 13.8% * 9.3% 21.8% 89.32% 5
10 Yr 8.5% * 6.1% 15.7% 83.84% 5

* Annualized


Return Ranking - Calendar

Period GGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -13.8% -29.8% 2.6% 45.45% 3
2015 -10.9% -20.4% 14.5% 89.09% 5
2014 7.9% -5.8% 33.7% 78.18% 4
2013 30.5% -2.6% 65.2% 67.89% 4
2012 12.1% -5.3% 36.5% 54.37% 3

Total Return Ranking - Trailing

Period GGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 17.9% -14.9% 33.8% 70.27% 4
1 Yr 5.6% -18.3% 41.2% 88.18% 5
3 Yr 2.5% * -14.2% 18.2% 95.37% 5
5 Yr 12.5% * 9.1% 21.8% 96.12% 5
10 Yr 7.8% * 6.1% 15.7% 93.94% 5

* Annualized


Total Return Ranking - Calendar

Period GGHCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -13.8% -25.1% 6.3% 48.62% 3
2015 -10.9% -16.6% 39.1% 95.41% 5
2014 23.1% -5.8% 100.0% 79.82% 4
2013 58.2% -5.1% 398.7% 69.44% 4
2012 34.5% -2.6% 475.8% 59.00% 3

NAV & Total Return History

GGHCX - Holdings

Filings data as of: Mar 31, 2017

Concentration Analysis

GGHCX Category Low Category High GGHCX % Rank Quintile
Net Assets 1.45 B 20.8 M 48.3 B 15.18% 3
Number of Holdings 76 32 365 19.64% 3
Net Assets in Top 10 532 M 9.25 M 20.1 B 17.86% 3
Weighting of Top 10 37.4% 19.5% 71.8% 27.68% 4

Top 10 Holdings

  1. Roche Holding AG Dividend Right Cert. 2.82%
  2. Shire PLC ADR 4.97%
  3. Merck & Co Inc 4.02%
  4. Celgene Corp 6.04%
  5. Biogen Inc 3.78%
  6. Thermo Fisher Scientific Inc 3.98%
  7. Eli Lilly and Co 3.03%
  8. Biomarin Pharmaceutical Inc 3.41%
  9. Vertex Pharmaceuticals Inc 2.71%
  10. Incyte Corp 2.64%

Asset Allocation

Weighting Category Low Category High GGHCX % Rank Quintile
Stocks
94.92% 85.65% 102.85% 30.36% 5
Cash
5.08% -0.06% 14.35% 3.57% 1
Preferred Stocks
0.00% 0.00% 0.71% 5.36% 4
Other
0.00% -11.71% 7.50% 16.07% 4
Convertible Bonds
0.00% 0.00% 0.49% 3.57% 4
Bonds
0.00% 0.00% 5.97% 4.46% 4

Stock Sector Breakdown

Weighting Category Low Category High GGHCX % Rank Quintile
Healthcare
93.99% 11.52% 99.64% 21.43% 3
Technology
0.49% 0.00% 64.38% 22.32% 3
Consumer Defense
0.44% 0.00% 2.14% 10.71% 2
Utilities
0.00% 0.00% 1.11% 1.79% 4
Real Estate
0.00% 0.00% 1.50% 2.68% 4
Industrials
0.00% 0.00% 8.05% 10.71% 4
Financial Services
0.00% 0.00% 5.16% 6.25% 4
Energy
0.00% 0.00% 0.00% 0.89% 4
Communication Services
0.00% 0.00% 0.00% 0.89% 4
Consumer Cyclical
0.00% 0.00% 5.10% 6.25% 4
Basic Materials
0.00% 0.00% 1.96% 4.46% 4

Stock Geographic Breakdown

Weighting Category Low Category High GGHCX % Rank Quintile
US
79.48% 59.77% 99.64% 28.57% 4
Non US
15.44% 0.00% 40.28% 8.04% 2

GGHCX - Expenses

Operational Fees

GGHCX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.09% 0.10% 4.31% 51.79% 2
Management Fee 0.62% 0.09% 1.25% 12.50% 2
12b-1 Fee 0.25% 0.00% 1.00% 8.86% 2
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

GGHCX Fees (% of AUM) Category Low Category High GGHCX Rank Quintile
Front Load 5.50% 3.50% 5.75% 7.69% 2
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

GGHCX Fees (% of AUM) Category Low Category High GGHCX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

GGHCX Fees (% of AUM) Category Low Category High GGHCX Rank Quintile
Turnover 21.00% 0.00% 699.00% 25.00% 2

GGHCX - Distributions

Dividend Yield Analysis

GGHCX Category Low Category High GGHCX % Rank Quintile
Dividend Yield 0.0% 0.01% 0.94% 82.98% 5

Dividend Distribution Analysis

GGHCX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

GGHCX Category Low Category High GGHCX % Rank Quintile
Net Income Ratio 0.23% -2.22% 1.40% 15.18% 1

Capital Gain Distribution Analysis

GGHCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

GGHCX - Managers

Derek Taner

Manager

Start Date

Apr 29, 2005

Tenure

12.18

Tenure Rank

6.8%

Derek Taner is the lead portfolio manger for the Invesco Global Health Care team. Mr. Taner joined Invesco in 2005, coming from Franklin Advisers Inc. where he served as a portfolio manager on Franklin Templeton’s health care team from 2002 through 2005 — the fi nal two years as lead manager. He began his investment career in 1993 as a fi xed-income analyst with Franklin Templeton and was promoted to assistant portfolio manager in 1997. In 2000, he joined the fi rm’s equity department and was named co-manager of its equity-income product. Mr. Taner earned a Bachelor of Science degree in business administration with an emphasis in accounting and fi nance and a Master of Business Administration degree from the Haas School of Business at the University of California (Berkeley). He is a CFA charterholder.


Henry Wu

Manager

Start Date

Feb 28, 2017

Tenure

0.33

Tenure Rank

26.2%

Henry Wu, Portfolio Manager, has been associated with Invesco and/or its affiliates since 2014 (and was previously associated with Invesco and/or its affiliates from 2006 to 2010). From 2012 to 2013, he was employed by Scopia Capital as a senior analyst. From 2010 to 2012, he was employed by Surveyor Capital/Citdadel Investment Group as an analyst.


Tenure Analysis

Category Low

0.0

Category High

19.8

Category Average

8.78

Category Mode

2.5